A Study of Pregnancy Outcomes in Congenital Heart Disease

Withdrawn before enrolling

Conditions studied: Congenital Heart Disease

In brief

The purpose of this study is to determine if a biomarker assay obtained peripartum (1st-3rd trimester and post-partum) in patients with adult congenital heart disease can predict future risk of cardiovascular adverse events and determine if temporal changes in biomarkers levels throughout the peripartum period can provide a better risk prediction compared to samples taken at a single time-point.

Key facts

Study ID

NCT06678256

Run by

Mayo Clinic

People needed

0

Starts

2026-01-01

Expected to finish

2026-11-01

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Congenital Heart Disease Diagnosis
• Currently Pregnant

You may not qualify if…

• Unable to consent

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.